2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Polycystic Ovary Syndrome
18
Carcinoma, Non-Small-Cell Lung
14
Colorectal Neoplasms
11
Lung Neoplasms
9
Recurrence
7
Neoplasm Metastasis
5
Colonic Neoplasms
5
Breast Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Infertility
4
Neoplasms
3
Lymphoma, T-Cell
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sezary Syndrome
2
Papillomavirus Infections
2
Mycosis Fungoides
2
Meningeal Carcinomatosis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, B-Cell
2
Lymphoma
2
Insulin Resistance
2
Infertility, Female
2
Hyperandrogenism
2
Head and Neck Neoplasms
2
Diabetes, Gestational
2
Carcinoma, Transitional Cell
2
Atypical Squamous Cells of the Cervix
2
Interventions
Pemetrexed
40
Cisplatin
35
pembrolizumab
21
Nivolumab
17
Carboplatin
16
Ipilimumab
13
Gemcitabine
10
Cyclophosphamide
9
fludarabine
6
durvalumab
6
Bevacizumab
6
Radiotherapy, Intensity-Modulated
4
LMB-100
4
Drug Therapy
4
Dexamethasone
4
tremelimumab
3
tazemetostat
3
spartalizumab
3
olaparib
3
niraparib
3
atezolizumab
3
anetumab ravtansine
3
amatuximab
3
Vinorelbine
3
Paclitaxel
3
Oxaliplatin
3
Imatinib Mesylate
3
Fluorouracil
3
Cerebral Decortication
3
Blood Specimen Collection
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma
×
Folic Acid
×
Clear all
NCT01569919
2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2
Unknown
26 enrolled